Answers are grounded in this paper and cite their sources.
Investigates anticancer activity of Ru(II) complexes in triple-negative breast cancer, suggesting effective treatment potential.
Ru( ii )-naphthoquinone complexes are effective against human triple-negative breast cancer (MDA-MB-231). Flow cytometry and western blotting confirmed the mechanism of action via apoptosis induced by reactive oxygen species (ROS).
No takes yet. Share an insight, caveat, or question.
Costa et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: